Cargando…
Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma
Cutaneous squamous cell carcinomas (cSCC) represent one of the most diagnosed non-melanoma skin cancers and its incidence is increasing globally. Whereas early stage and low risk cSCC is typically treated with surgery, and in some cases other localized therapeutic modalities, locally advanced or met...
Autores principales: | Aboul-Fettouh, Nader, Morse, Daniel, Patel, Jigar, Migden, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609954/ https://www.ncbi.nlm.nih.gov/pubmed/34877077 http://dx.doi.org/10.5826/dpc.11S2a169S |
Ejemplares similares
-
Advances in Cutaneous Squamous Cell Carcinoma Management
por: Burns, Carrick, et al.
Publicado: (2022) -
Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma
por: Chen, Olivia M., et al.
Publicado: (2022) -
Aggressive squamous cell carcinoma in a patient on the Janus kinase inhibitor ruxolitinib
por: Aboul-Fettouh, Nader, et al.
Publicado: (2018) -
Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy
por: Ishitsuka, Yosuke, et al.
Publicado: (2021) -
Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma
por: Boutros, Andrea, et al.
Publicado: (2021)